News Overview

J Kumar Infraprojects's net profit also increased by 14.3% to ₹114 crore in the quarter ended on March 31, 2025 from ₹99.7 crore in the year ago period.

Revenue increased 34.5% YoY to ₹2,166.6 crore, compared to ₹1,610.7 crore in Q4 FY24.

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

The company's EBITDA on the operating front fell 3.2% to ₹ 318.3 crore compared to ₹ 328.9 crore in the year-ago period.

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

Revenue from operations increased by 38.8% YoY to ₹163 crore against ₹117.4 crore reported in the corresponding period last year.

Bharat Elec is the only stock to hits 52-week high in Nifty

The Board has proposed a final dividend of ₹6 per share and has also approved a new dividend policy of giving back up to 75% of free cash flow in the future.

This latest order enlarges TCS’s continued engagement with BSNL to modernise the state-run telecom operator’s mobile infrastructure.

Most of the IPO proceeds will be used for deleveraging, allowing for better margins and financial flexibility.